[1] Hille R. The mononuclear molybdenum enzymes[J]. Chem Rev, 1996, 962: 2 757-2 816.
[2] Yamase T. Polyoxometalates for molecular devices: antitumor activity and luminescence[J]. Molecular Engineering, 1993, 3: 241-262.
[3] Louis Y K, Mercouri G K, Michal S, et al. Metallocene antitumor agents. Solution and solid-state molybdencene coordination chemistry of DNA constituents[J]. J Am Chem Soc, 1991, 113: 9 027-9 036.
[4] Quintin, Kleer C G. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis[J]. Cancer Research, 2002, 62: 4 854-4 858.
[5] Yamase T, Ishikawa E. Proton magnetic resonance study of divalent metal ions binding to adenosine 5′-triphosphate[J]. J Inorg Biochem, 2006, 100: 344-350.
[6] Lu Xiao-ming(鲁晓明), Deng Yuan(邓元), Li Li(李丽), et al. Biomemic synthesis, crystal structure of molybdenum and tungsten chiral octahedral complex (NH3CH2CH2CH2NH2)2[Mo0.4W0.6O2(C6H4O2)2] and its interaction with ATP by 1H, 13C, 31P and 15N NMR(1, 3-丙二胺邻苯二酚钼钨手性八面体配合物的仿生合成、晶体结构以及与ATP作用的液相NMR研究)[J]. Chemical Journal of Chinese Universities(高等学校化学学报), 2005, 26(4): 611-616.
[7] Lu Xiao-ming(鲁晓明). The synthesis, crystal structure, EPR, UV, NMR and properties study of molybdenum and tungsten complexes(钼、 钨金属配合物的合成、晶体结构、EPR、UV、NMR以及性质研究)[D]. Wuhan(武汉): Wuhan Institute of Physics and Mathematics(武汉物理与数学研究所), 2002.
[8] Lu X M, Jiang L, Mao X A, et al. Interactions with ATP, DNA cleavage and anti-tumor activities of complexes with anions[Mo(Ⅴ)O2(O2C6H4)2]3-, [Mo(Ⅴ)0.5W(Ⅵ)0.5O2(O2C6H4)2]2.5- and [W(Ⅵ)O2(O2C6H4)2]2-[J]. Chinese Journal of Chemistry, 2003, 23(6): 781-785.
[9] Song Fu-gen(宋福根), Lu Xiao-ming(鲁晓明), Yu Chong(喻冲), et al. Synthesis, crystal structure of (NH3CH2CHNH2CH3)3[W(VI)O2(OC6H4O)2] and its NMR studies on the interaction with ATP. (NH3CH2CHNH2CH3)3[W(VI)O2(OC6H4O)2]的合成、晶体结构及其与ATP相互作用的NMR性质研究) [J]. Chinese Journal of Chemistry(中国化学), 2009, 67(11): 1 195-1 200. |